Počet záznamov: 1
abciximab
SYS d000077284 LBL 00000cx^^^2200181-^^45^^ 005 20240119195327.2 100 $a 20190101asloy0103 ba0 152 $b mesh 250 $a abciximab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2019 (1994) $8 eng 330 1-
$a A Fab fragment of the chimeric monoclonal antibody 7E3 that binds to the glycoprotein IIb-IIIa receptor of human platelets, and blocks PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX, potently inhibiting PLATELET AGGREGATION. It is used in treatment of refractory unstable angina, and for prevention of ischemic complications in patients undergoing percutaneous coronary procedures such as ANGIOPLASTY; ATHERECTOMY; or stenting. $8 eng 450 $a CentoRx $5 e $8 slo 450 $a 7E3 Fab chimerický $5 e $8 slo 450 $a Clotinab $5 e $8 slo 450 $a ReoPro $5 e $8 slo 450 $a c7E3 Fab $5 e $8 slo 686 $a D12.644.541.500.650.125 686 $a D12.776.124.486.485.114.224.060.125 686 $a D12.776.124.486.485.680.650.125 686 $a D12.776.124.790.651.114.224.060.125 686 $a D12.776.124.790.651.680.650.125 686 $a D12.776.377.715.548.114.224.200.125 686 $a D12.776.377.715.548.680.650.125 750 $a Abciximab $8 eng 801 -0
$a SK $b BA006 $c 20190310 801 -2
$a SK $b BA006 $c 20190313 801 -2
$a SK $b BA006 $c 20201203 801 -2
$a SK $b BA006 $c 20230119 980 $x M
Počet záznamov: 1